Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Clin Lipidol. 2016 Feb 16;10(3):610–618. doi: 10.1016/j.jacl.2016.01.007

Table 3.

Lipids and Lipoprotein Values in the Study Population

Variable Obese
Normoglycemic
n=118
Obese Pre-diabetic
N=96
p value
Lipids (mg/dl)
Total cholesterol 172 (147, 193) 169 (149, 192) 0.85
LDL cholesterol 102 (85, 121) 102 (86, 128) 0.62
HDL cholesterol 47 (42, 54) 45 (41, 51) 0.25
Triglycerides 81 (60, 111) 86 (62, 113) 0.44
Lipoprotein Particle Concentrations
LDL-P (nmol/L)
Total 1037 (834, 1266) 1098 (898, 1353) 0.10
Large 527 (398, 649) 484 (393, 648) 0.46
Small 426 (247,559) 468 (339, 673) 0.010
IDL-P (nmol/L) 124.5 (72.0, 177.0) 106.5 (63.5, 160.5) 0.19
HDL-P (µmol/L)
Total 32.2 (28, 38.8) 31.9 (29.5, 36.6) 0.75
Large 4.4 (3.1, 6.1) 4.0 (2.4, 5.2) 0.027
Intermediate 12.5 (9.2, 15.5) 10.8 (8.3, 13.0) 0.007
Small 15.6 (12.7, 18.3) 17.2 (14.5, 19.7) 0.004
VLDL_P (nmol/L)
Total 2.4 (1.3, 4.0) 2.5 (1.5, 4.2) 0.72
Large 43.2 (26.5, 60.6) 41.8 (25.1, 56.8) 0.71
Intermediate 13.7 (7.9, 26.8) 11.8 (7.5, 23.4) 0.64
Small 23.7 (14.6, 33.9) 21.7 (14.7, 32.3) 0.53
Lipoprotein Particle Size (nm)
LDL 21.1 (20.8, 21.4) 21 (20.6, 21.3) 0.033
HDL 9.0 (8.7, 9.3) 8.8 (8.6, 9.1) 0.010
VLDL 47.2 (44.1, 51.3) 47.8 (44.1, 51.6) 0.58

Values are median (Q1, Q3).